Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Marine collagen for regenerative medicine: Structure-function advantages, limitations, and translational pathways

Yuan R., Huang W., Liu H., Wu J., Yu H., Zhao X.

Narrative Review on Immune Modulation, published in Bioact Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Bioact Mater (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41909507
PMCID
PMC13019082
DOI
10.1016/j.bioactmat.2026.03.013

Abstract (original English)

Marine collagen is emerging as a transformative natural-derived material in regenerative medicine. Unlike traditional mammalian collagen, it has unique structural properties (e.g., a distinct amino acid profile) that confer high biocompatibility and low immunogenicity, along with excellent antibacterial activity and a sustainable supply chain that eliminates zoonotic disease risks. This review establishes the foundational rationale for this shift by conducting a comprehensive analysis of the structure-function relationships underpinning the regenerative superiority of marine collagen. We critically evaluate how advanced manufacturing technologies (e.g., 3D bioprinting, electrospinning) leverage these intrinsic properties to deliver transformative therapeutic outcomes, exemplified by biomechanically optimized cartilage scaffolds and immunomodulatory wound matrices. Our review also delineates actionable pathways for clinical translation, addressing challenges in scalability, regulatory compliance, and long-term stability. This review uniquely integrates structure-function relationships with green industrialization pathways, offering an actionable framework for clinical translation of marine collagen, which repositions marine collagen from a mere alternative to an indispensable platform material, poised to drive the next generation of regenerative therapies.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research